ATS 2019 Virtual Final Program

419 Lung Cancer Screening: What You Don’t Know Might Not Hurt/ L. Schweiger, S. Golden, A.C. Melzer, S. Datta, C.G. Slatore, Portland, OR, p.A4487 420 Adherence to Annual Lung Cancer Screening/ A. Vachani, C. Saia, M.D. Schnall, C.A. Doubeni, K.A. Rendle, Philadelphia, PA, p.A4488 BASIC • TRANSLATIONAL THEMATIC POSTER SESSION C31 TRANSLATIONAL STUDIES IN SARCOIDOSIS 9:15 a.m. - 4:15 p.m. KBHCCD Area C (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : A.K. Gerke, MD, Iowa City, IA P237 Proteomic Profiling of Serum Exosomes to Find Novel Biomarkers in Sarcoidosis/ Y. Futami, Y. Takeda, T. Koba, H. Kida, A. Kumanogoh, K. Ueda, Suita City, Japan, p.A4489 P238 Periostin Is a Novel Biomarker for Sarcoidosis/ T. Isshiki, H. Matsuyama, H. Shimizu, T. Yamaguchi, J. Ono, S. Nunomura, K. Izuhara, S. Sakamoto, S. Homma, Tokyo, Japan, p.A4490 P239 Clinical Significance of Anti-SSA Antibodies in Patients with Sarcoidosis/ C. Vagts, C. Ascoli, N. Sweiss, Chicago, IL, p.A4491 P240 CCL20 and Its Association with Disease Activity and Severity in Sarcoidosis/ M. Ando, I. Kaishiakuji, E. Watanabe, T. Kan, N. Fujita, T. Hashimoto, T. Masuda, Y. Usagawa, C. Yasuda, E. Mizukami, M. Yamasue, K. Hashinaga, K. Komiya, K. Umeki, S.-I. Nureki, K. Hiramatsu, J. Kadota, Yufu, Japan, p.A4492 P241 CXCL9 and CXCL10 Predict Different Aspects of Sarcoidosis Disease Severity/ N. Arger, M. Ho, P. Woodruff, L. Koth, San Francisco, CA, p.A4493 P242 Composite Physiologic Index Is Not a Surrogate for Sarcoidosis Prognosis in Patients with Neurosarcoidosis/ P. Barletta, C. Rodriguez, G. Urdaneta, I.S. Jabeen, M. Mirsaeidi, Miami, FL, p.A4494 P243 PET/CT Scan as a Surrogate for Treatment Outcomes in Sarcoidosis/ N.S. Khakoo, S. Jabeen Isma, M.A. Campos, G. Holt, M. Mirsaeidi, Miami, FL, p.A4495 P244 Characteristic of PET/CT Scan in Sarcoidosis/ S. Jabeen Isma, N.S. Khakoo, G. Urdaneta, M. Mirsaeidi, Miami, FL, p.A4496 P245 Ocular Manifestations of Sarcoidosis in South Florida Population/ N. Cotorruelo Martinez, L. Diana, P.A. Barletta, M. Farhangi, J. Davis, R. Goldhardt, A. Galor, M. Mirsaeidi, Florida, FL, p.A4497 Facilitator : R. Raj, MD, Palo Alto, CA P246 Sarcoidosis in Patients with Previous Diagnosis of Cancer/ M. Murthi, S. Jabeen Isma, H. Asif, G.E. Holt, M. Mirsaeidi, Miami, FL, p.A4498 P247 Metals and Silica as Possible Antigens in Dutch Sarcoidosis Patients/ E. Beijer, H. Kromhout, B. Meek, M. Veltkamp, Nieuwegein, Netherlands, p.A4499 P248 Human Sarcoidosis Vs TB: All Granulomas Are Not Created Equally/ L.W. Locke, P. White, M.W. Julian, S. Bicer, A. Papp, W. Sadee, L.S. Schlesinger, E.D. Crouser, Columbus, OH, p.A4500 P249 Analysis of Predictive Factors for the Diagnostic Yield with Transbronchial Biopsy in Sarcoidosis/ E. Watanabe, M. Ando, I. Kaishakuji, T. Kan, N. Fujita, T. Hashimoto, T. Masuda, Y. Usagawa, C. Yasuda, E. Mizukami, M. Yamasue, K. Hashinaga, T. Isii, K. Komiya, K. Umeki, S.-I. Nureki, K. Hiramatsu, E. Miyazaki, J.-I. Kadota, Yufu, Japan, p.A4501 P250 Immune Evasive Mechanisms Prompted by CD8+ T Cell Dysregulation in Sarcoidosis Local and Systemic Environments/ L.J. Celada, A. Abad, G. Shaginurova, O.S. Chioma, W. Luo, K. Abel, K.A. Richter, W.P. Drake, Nashville, TN, p.A4502 P251 Alveolar Macrophage ABCG1 Deficiency Promotes Carbon Nanotube Induced Pulmonary Granulomatous Inflammation/ E. Soliman, M. McPeek, A. Malur, D.A. Tokarz, G. Murray, K.M. Gowdy, C. Wingard, M.B. Fessler, B. Barna, M.J. Thomassen, Greenville, NC, p.A4503 P252 The Role of IL-17A in the Mouse Model of Sarcoid Granulomatous Mice Induced by Propionibacterium Acnes/ D. Weng, J. Song, H. Li, Shanghai, China, p.A4504 P253 PPARgamma Deficiency Promotes an Adaptive T Lymphocyte Response to Mycobacterial Antigen ESAT-6 in a Murine Model of Chronic Pulmonary Sarcoidosis/ A. Malur, V. Sanderford, N. Leffler, A. Mohan, R.A. Barrington, K. Kew, B.P. Barna, M.J.J. Thomassen, Greenville, NC, p.A4505 P254 a -Melanocyte Stimulating Hormone Has Anti-Inflammatory Properties in Granuloma Via Marco and p-CREB/ C. Zhang, G.E. Holt, K.R. Schesser, N.H. Altman, R.M. Jackson, A.V. Schally, M. Mirsaeidi, Miami, FL, p.A4506 Facilitator : A. Sclafani, MD, Boston, MA P255 A Study of Lymphocyte Subsets in Sarcoidosis/ A. Sommer, San Francisco, CA, p.A4507 P256 The Role of Pharmacogenetics in Sarcoidosis/ C.E. Rodriguez Buljubasich, A. Batri, P.A. Barletta, G. Urdaneta, I.A. Vital, M. Mirsaeidi, I. Forghani, Miami, FL, p.A4508 P257 Pharmacogenetics of Methotrexate in Sarcoidosis Patients/ A.S. Calzadilla, C. Rodriguez Buljubasich, B. Anthony, I. Forghani, M. Mirsaeidi, Miami, FL, p.A4509 P258 Transcriptional and Epigenomic Profiling of Bronchoalveolar Lavage Immune Cells in Sarcoidosis/ M.J. Alexander, G. Gadhvi, J.M. Walter, K. Helmin, B.D. Singer, G.S. Budinger, D.R. Winter, P.H.S. Sporn, Chicago, IL, p.A4510 P259 Differential Expression of Monocyte Cell Surface Proteins in Pulmonary Sarcoidosis/ S. Machiraju, N. Arger, B. Benn, A. Sommer, N. Bhakta, L. Koth, San Francisco, CA, p.A4511 ATS 2019 • Dallas, TX 240 TUESDAY • MAY 21